(4) Monoclonal antibodies (mAbs): Anti-CD38 monoclonal antibodies, such as daratumumab, isatuximab, target overexpressed CD38 on MM cells, block cell adhesion and proliferation, and induce cell apoptosis. This evidence concerns the gene CD38 and Miyoshi myopathy.